{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T06:11:39Z","timestamp":1792044699201,"version":"4.4.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplant Immunology"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.trim.2022.101587","type":"journal-article","created":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T12:52:00Z","timestamp":1648039920000},"page":"101587","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Seroprevalence of Cytomegalovirus antibodies and primary infection among hemodialysis patients: A systematic and meta-analysis review"],"prefix":"10.1016","volume":"72","author":[{"given":"Negin","family":"Mesgar Saravi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tahoora","family":"Mousavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trim.2022.101587_bb0005","article-title":"Dietary interventions for kidney health","author":"Brown-Tortorici","year":"2020","journal-title":"Nutrition"},{"issue":"4","key":"10.1016\/j.trim.2022.101587_bb0010","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1002\/ejhf.1697","article-title":"Evaluation of kidney function throughout the heart failure trajectory\u2013a position statement from the heart failure Association of the European Society of cardiology","volume":"22","author":"Mullens","year":"2020","journal-title":"Eur. J. Heart Fail."},{"issue":"1&2","key":"10.1016\/j.trim.2022.101587_bb0015","first-page":"36","article-title":"Seroepidemiological study of cytomegalovirus in haemodialysis patients hospitalized in heamodialysis unit of Jahrom, journal of microbial","volume":"4","author":"Hemayatkhah Jahromi","year":"2011","journal-title":"World"},{"issue":"3","key":"10.1016\/j.trim.2022.101587_bb0020","first-page":"155","article-title":"Seroprevalence of cytomegalovirus antibodies in haemodialysis patients","volume":"36","author":"Ocak","year":"2006","journal-title":"Turkish Journal of Medical Sciences"},{"issue":"12","key":"10.1016\/j.trim.2022.101587_bb0025","first-page":"49","article-title":"Association of cytomegalovirus seroprevalence and blood transfusion among patients undergoing chronic hemodialysis","volume":"2","author":"ElSaid","year":"2015","journal-title":"IJMPRS"},{"issue":"2","key":"10.1016\/j.trim.2022.101587_bb0030","doi-asserted-by":"crossref","first-page":"95","DOI":"10.4103\/0971-4065.139488","article-title":"Prevalence and dynamics of cytomegalovirus infection among patients undergoing chronic hemodialysis","volume":"25","author":"Vilibic-Cavlek","year":"2015","journal-title":"Indian journal of nephrology"},{"issue":"12","key":"10.1016\/j.trim.2022.101587_bb0035","first-page":"160","article-title":"ALazi, Seroprevalence of human cytomegalovirus among hemodialysis patients in Diayala province","volume":"3","author":"Salman","year":"2014","journal-title":"Int J Curr Microbiol Appl Sci"},{"issue":"1","key":"10.1016\/j.trim.2022.101587_bb0040","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.2017","article-title":"Going beyond serology for stratifying the risk of CMV infection in transplant recipients","volume":"29","author":"Navarro","year":"2019","journal-title":"Rev. Med. Virol."},{"issue":"1","key":"10.1016\/j.trim.2022.101587_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-018-3195-5","article-title":"Cytomegalovirus infection and outcome in immunocompetent patients in the intensive care unit: a systematic review and meta-analysis","volume":"18","author":"Li","year":"2018","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.trim.2022.101587_bb0050","doi-asserted-by":"crossref","DOI":"10.1100\/2012\/820621","article-title":"Viral infection in renal transplant recipients","volume":"2012","author":"Cukuranovic","year":"2012","journal-title":"Sci. World J."},{"key":"10.1016\/j.trim.2022.101587_bb0055","first-page":"2523","article-title":"Frequency of CMV-infection among hemodialysis patients in Tikrit City","volume":"56","author":"Saadoon","year":"2015","journal-title":"Iraqui J Sci"},{"issue":"199","key":"10.1016\/j.trim.2022.101587_bb0060","first-page":"179","article-title":"Epidemiology of cytomegalovirus among patients undergoing hemodialysis in sari, Iran 2017-2018","volume":"31","author":"Aghajanian","year":"2021","journal-title":"Journal of Mazandaran University of Medical Sciences"},{"issue":"4","key":"10.1016\/j.trim.2022.101587_bb0065","first-page":"19","article-title":"Prevalence of active cytomegalovirus infection in hemodialysis patients","volume":"11","author":"Kelishadi","year":"2017","journal-title":"Medical Laboratory Journal"},{"key":"10.1016\/j.trim.2022.101587_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.exger.2021.111337","article-title":"Cytomegalovirus and herpes simplex type 1 infections and immunological profile of community-dwelling older adults","volume":"149","author":"Noronha","year":"2021","journal-title":"Exp. Gerontol."},{"issue":"9","key":"10.1016\/j.trim.2022.101587_bb0075","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur. J. Epidemiol."},{"key":"10.1016\/j.trim.2022.101587_bb0080","article-title":"Parvovirus B19 (B19) and cytomegalovirus (CMV) infections and anti-erythropoietin (anti-EPO) antibodies in patients on dialysis hyporesponsive to erythropoietin therapy","author":"Alves","year":"2014","journal-title":"Elsevier"},{"issue":"3","key":"10.1016\/j.trim.2022.101587_bb0085","first-page":"488","volume":"16","author":"Elmoumou","year":"2016","journal-title":"Int. J. Innov. Appl. Stud."},{"issue":"4","key":"10.1016\/j.trim.2022.101587_bb0090","doi-asserted-by":"crossref","first-page":"183","DOI":"10.4103\/1858-5000.133016","article-title":"Prevalence of IgG and IgM antibodies to human cytomegalovirus among Sudanese renal transplant recipients and haemodialysis patients","volume":"8","author":"Awadalkareem","year":"2013","journal-title":"Sudan Medical Monitor"},{"key":"10.1016\/j.trim.2022.101587_bb0095","series-title":"Detection of Antibody against Cytomegalovirus in Rejected Renal Transplant Recipients and Hemodialysis Patients in Khartoum State, 2018","author":"Saeed","year":"2018"},{"issue":"2","key":"10.1016\/j.trim.2022.101587_bb0100","first-page":"4441","article-title":"Detection of cytomegalovirus in patients with end stage renal disease in KIRKUK CITY","volume":"19","author":"Tofiq","year":"2019","journal-title":"Biochem. Cell. Arch."},{"issue":"12","key":"10.1016\/j.trim.2022.101587_bb0105","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1007\/s10096-011-1260-8","article-title":"Lack of evidence for systemic cytomegalovirus reactivation in maintenance hemodialysis patients","volume":"30","author":"Pliquett","year":"2011","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"issue":"2","key":"10.1016\/j.trim.2022.101587_bb0110","first-page":"33","article-title":"Prevalence of cytomegalovirus infection among patients undergoing hemodialysis","volume":"15","author":"El-Sadek","year":"2008","journal-title":"Egyptian Journal of Immunology"},{"key":"10.1016\/j.trim.2022.101587_bb0115","series-title":"Prevalence of cytomegalovirus infection in hemodialysis patients in Labbafinejad Hospital in 2002-2003","author":"AMIN","year":"2005"},{"issue":"6","key":"10.1016\/j.trim.2022.101587_bb0120","first-page":"18016","article-title":"Abd ElAziz, relation between metabolic syndrome and Cytomegalo virus in Haemodialysis patients","volume":"25","author":"Shaker","year":"2021","journal-title":"Annals of the Romanian Society for Cell Biology"},{"key":"10.1016\/j.trim.2022.101587_bb0125","series-title":"Sero-Detection of Cytomegalovirus Antibodies among Hemodialysis Patients in Khartoum State","author":"Abdelrahim","year":"2011"},{"issue":"1","key":"10.1016\/j.trim.2022.101587_bb0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12865-017-0194-z","article-title":"Validation of T-track\u00ae CMV to assess the functionality of cytomegalovirus-reactive cell-mediated immunity in hemodialysis patients","volume":"18","author":"Banas","year":"2017","journal-title":"BMC Immunol."},{"issue":"2","key":"10.1016\/j.trim.2022.101587_bb0135","first-page":"363","article-title":"Survey the seroprevalence of CMV among hemodialysis patients in Urmia, Iran","volume":"21","author":"Sepehrvand","year":"2010","journal-title":"Saudi Journal of Kidney Diseases and Transplantation"},{"issue":"1","key":"10.1016\/j.trim.2022.101587_bb0140","doi-asserted-by":"crossref","first-page":"269","DOI":"10.37557\/gjphm.v3i1.80","article-title":"PREVALENCE AND RISK FACTORS OF CYTOMEGALOVIRUS INFECTION AMONG HAEMODIALYSIS PATIENTS IN SOUTHERN GAZA STRIP","volume":"3","author":"Abed El Kader","year":"2021","journal-title":"PALESTINE, Global Journal of Public Health Medicine"},{"issue":"2","key":"10.1016\/j.trim.2022.101587_bb0145","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1046\/j.1523-1755.2003.00120.x","article-title":"The role of hyperparathyroidism, erythropoietin therapy, and CMV infection in the failure of arteriovenous fistula in hemodialysis","volume":"64","author":"Grandaliano","year":"2003","journal-title":"Kidney Int."},{"issue":"7","key":"10.1016\/j.trim.2022.101587_bb0150","first-page":"19","article-title":"Seroprevalence of cytomegalovirus antibodies among hemodialysis patients in Gezira state, Central Sudan, world","volume":"4","author":"Abd Alla","year":"2015","journal-title":"J. Pharm. Res."},{"key":"10.1016\/j.trim.2022.101587_bb0155","unstructured":"O. Bushera, The prevalence of cytomegalovirus antibodies in kidney candidate recipients, kidney candidate donors and blood donors at Ahmed Gasim Renal Transplant Centre, UOFK."},{"issue":"11","key":"10.1016\/j.trim.2022.101587_bb0160","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1128\/CVI.05228-11","article-title":"National prevalence estimates for cytomegalovirus IgM and IgG avidity and association between high IgM antibody titer and low IgG avidity","volume":"18","author":"Dollard","year":"2011","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.trim.2022.101587_bb0165","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1590\/S0037-86822010000400004","article-title":"Seroprevalence of cytomegalovirus antibodies in blood donors in southern, Brazil","volume":"43","author":"Souza","year":"2010","journal-title":"Rev. Soc. Bras. Med. Trop."}],"container-title":["Transplant Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327422000612?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327422000612?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T18:01:59Z","timestamp":1760810519000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0966327422000612"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":33,"alternative-id":["S0966327422000612"],"URL":"https:\/\/doi.org\/10.1016\/j.trim.2022.101587","relation":{},"ISSN":["0966-3274"],"issn-type":[{"value":"0966-3274","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Seroprevalence of Cytomegalovirus antibodies and primary infection among hemodialysis patients: A systematic and meta-analysis review","name":"articletitle","label":"Article Title"},{"value":"Transplant Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trim.2022.101587","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101587"}}